MedTrace Logo

Honest, Open, Proud for Soldiers with Mental Illness

NCT03218748 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2024-12-11

No results posted yet for this study

Summary

The purpose of the study is to evaluate the feasibility and efficacy of the group-based intervention "Honest, Open, Proud" among soldiers with mental illness.

Conditions

  • Mental Illness

Interventions

BEHAVIORAL

Honest, Open, Proud (HOP)

Three lessons, one for each two-hour session plus one booster session 1. Considering the pros and cons of disclosure: Discussion of one's idea of identity and mental illness, weighing the costs and benefits of (non-) disclosure 2. Different ways to disclose: Discussion of different levels of (non-) disclosure, considering costs and benefits of each level, selecting persons to disclose to and how to test them out, anticipating responses of others to one's disclosure 3. Telling one's story: Practice how to tell one's story, identifying peers who might be helpful with the coming out process 4. Booster session Reviewing previous intentions to disclose one's mental illness, discussion whether one disclosed and evaluating this experience

Sponsors & Collaborators

  • Center for Military Mental Health, Berlin, Germany

    collaborator UNKNOWN

  • Illinois Institute of Technology, Chicago, USA

    collaborator UNKNOWN

  • University of Ulm

    lead OTHER

Principal Investigators

  • Nicolas Rüsch, Dr. · Department of Psychiatry II, Section Public Mental Health, Ulm University, Bezirkskrankenhaus Günzburg

  • Gerd-Dieter Willmund, Dr. · Center for Military Mental Health, Berlin, Germany

  • Peter Zimmermann, Dr. · Center for Military Mental Health, Berlin, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-15
Primary Completion
2024-10-01
Completion
2024-10-01

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03218748 on ClinicalTrials.gov